BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Diagnosis
12 results:

  • 1. Diagnostic Accuracy of Blood-based Biomarkers for pancreatic cancer: A Systematic Review and Meta-analysis.
    Kane LE; Mellotte GS; Mylod E; O'Brien RM; O'Connell F; Buckley CE; Arlow J; Nguyen K; Mockler D; Meade AD; Ryan BM; Maher SG
    Cancer Res Commun; 2022 Oct; 2(10):1229-1243. PubMed ID: 36969742
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Lead-Time Trajectory of CA19-9 as an Anchor Marker for pancreatic cancer Early Detection.
    Fahrmann JF; Schmidt CM; Mao X; Irajizad E; Loftus M; Zhang J; Patel N; Vykoukal J; Dennison JB; Long JP; Do KA; Zhang J; Chabot JA; Kluger MD; Kastrinos F; Brais L; Babic A; Jajoo K; Lee LS; Clancy TE; Ng K; Bullock A; Genkinger J; Yip-Schneider MT; Maitra A; Wolpin BM; Hanash S
    Gastroenterology; 2021 Mar; 160(4):1373-1383.e6. PubMed ID: 33333055
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma.
    Yu S; Li Y; Liao Z; Wang Z; Wang Z; Li Y; Qian L; Zhao J; Zong H; Kang B; Zou WB; Chen K; He X; Meng Z; Chen Z; Huang S; Wang P
    Gut; 2020 Mar; 69(3):540-550. PubMed ID: 31562239
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Soluble stroma-related biomarkers of pancreatic cancer.
    Resovi A; Bani MR; Porcu L; Anastasia A; Minoli L; Allavena P; Cappello P; Novelli F; Scarpa A; Morandi E; Falanga A; Torri V; Taraboletti G; Belotti D; Giavazzi R
    EMBO Mol Med; 2018 Aug; 10(8):. PubMed ID: 29941541
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Plasma protein profiling of patients with intraductal papillary mucinous neoplasm of the pancreas as potential precursor lesions of pancreatic cancer.
    Ilies M; Sappa PK; Iuga CA; Loghin F; Gesell Salazar M; Weiss FU; Beyer G; Lerch MM; Völker U; Mayerle J; Hammer E
    Clin Chim Acta; 2018 Feb; 477():127-134. PubMed ID: 29221926
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Evaluation in pre-diagnosis samples discounts ICAM-1 and timp-1 as biomarkers for earlier diagnosis of pancreatic cancer.
    Jenkinson C; Elliott V; Menon U; Apostolidou S; Fourkala OE; Gentry-Maharaj A; Pereira SP; Jacobs I; Cox TF; Greenhalf W; Timms JF; Sutton R; Neoptolemos JP; Costello E
    J Proteomics; 2015 Jan; 113():400-2. PubMed ID: 25316052
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Adenocarcinoma arising in gastric heterotopic pancreas. Case report and review of the literature.
    Lemaire J; Delaunoit T; Molle G
    Acta Chir Belg; 2014; 114(1):79-81. PubMed ID: 24720145
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. pancreatic cancer clusters and arsenic-contaminated drinking water wells in Florida.
    Liu-Mares W; Mackinnon JA; Sherman R; Fleming LE; Rocha-Lima C; Hu JJ; Lee DJ
    BMC Cancer; 2013 Mar; 13():111. PubMed ID: 23510413
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Angiogenesis markers quantification in breast cancer and their correlation with clinicopathological prognostic variables.
    Rykala J; Przybylowska K; Majsterek I; Pasz-Walczak G; Sygut A; Dziki A; Kruk-Jeromin J
    Pathol Oncol Res; 2011 Dec; 17(4):809-17. PubMed ID: 21560015
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinical significance of the measurements of serum matrix metalloproteinase-9 and its inhibitor (tissue inhibitor of metalloproteinase-1) in patients with pancreatic cancer: metalloproteinase-9 as an independent prognostic factor.
    Mroczko B; Lukaszewicz-Zajac M; Wereszczynska-Siemiatkowska U; Groblewska M; Gryko M; Kedra B; Jurkowska G; Szmitkowski M
    Pancreas; 2009 Aug; 38(6):613-8. PubMed ID: 19629003
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.
    Wigmore SJ; Barber MD; Ross JA; Tisdale MJ; Fearon KC
    Nutr Cancer; 2000; 36(2):177-84. PubMed ID: 10890028
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Role of tumor markers and mutations in cells and pancreatic juice in the diagnosis of pancreatic cancer.
    Tascilar M; Caspers E; Sturm PD; Goggins M; Hruban RH; Offerhaus GJ
    Ann Oncol; 1999; 10 Suppl 4():107-10. PubMed ID: 10436798
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.